An elastin-like polypeptide is a recombinant protein polymer with a reversible temperature switch. Here's how ELPs are designed and where they are used.
An elastin-like polypeptide (ELP) is a recombinant protein polymer built from repeating amino acid sequences modeled on the hydrophobic region of human tropoelastin. ELPs are engineered in cells rather than extracted from tissue, and their defining trait is a reversible phase transition: they stay dissolved in cool water and separate into a cloudy coacervate as the solution warms. That temperature switch, not any resemblance to skin elastin, is what makes them useful in research.
What Is an Elastin-Like Polypeptide?
If you are asking what is a polypeptide, the short answer is a chain of amino acids linked by peptide bonds. An elastin-like polypeptide is one specific, engineered version of that idea, designed around a short sequence that repeats hundreds of times.
The repeating unit is a pentapeptide written as VPGXG: valine, proline, glycine, a variable "guest" residue, and glycine. The guest residue can be almost any amino acid except proline. In the most common natural motif, it is valine, giving VPGVG.
How the Guest Residue Changes Behavior
Sequence choice drives function. Replacing a hydrophobic guest residue such as valine with a charged one such as lysine raises the temperature at which the polymer separates out. Chain length matters too: longer ELPs transition at lower temperatures and form more stable aggregates. Polypeptide structure at that level, meaning sequence plus length, is the main design dial in ELP engineering.
How Elastin-Like Polypeptides Are Made
ELPs are encoded in synthetic DNA and expressed in bacterial, yeast, or plant systems. Because the sequence is defined at the gene level, batches are highly consistent compared with proteins purified from animal tissue.
- Genes are assembled from synthetic oligonucleotides, often using recursive directional ligation to build long repeat arrays.
- Host cells express the polymer, which accumulates inside the cell.
- Purification frequently uses inverse transition cycling, a salt-and-temperature method that can replace chromatography.
Common polypeptide examples in medicine include insulin, oxytocin, and pancreatic polypeptide, all of which the body produces on its own. ELPs have no natural counterpart circulating in humans; they borrow a motif from elastin but exist only because someone designed them.
The Phase Transition, Explained Simply
ELPs exhibit a lower critical solution temperature (LCST) in water. Below that point the polymer is soluble; above it, the chains self-associate into droplets and the solution turns milky. The process reverses on cooling and can be repeated many times without degrading the polymer.
Four variables control where the transition happens:
- Guest residue: more hydrophobic residues lower the transition temperature.
- Chain length: longer polymers transition at lower temperatures.
- Concentration: higher protein concentration lowers the transition point.
- Salt: kosmotropic salts such as sodium sulfate lower it, while chaotropic salts raise it.
Unlike many stimuli-responsive materials, ELPs transition over a narrow temperature range and are relatively insensitive to pH, which simplifies formulation work in the lab.
Elastin-Like Polypeptides Compared With Other Materials
| Feature | Elastin-like polypeptide | Natural elastin | PEG | Collagen-like peptide |
|---|---|---|---|---|
| Origin | Recombinant, engineered in host cells | Human and animal connective tissue | Synthetic polymer, not a peptide | Recombinant or synthetic repeats |
| Repeating motif | VPGXG pentapeptides | Cross-linked tropoelastin chains | Ethylene oxide units | Gly-X-Y triplets |
| Phase behavior | Reversible transition with temperature | Elastic fiber, no LCST | Fully water-soluble | Triple-helix assembly |
| Typical research use | Purification tags, drug depots, hydrogels | Material and tissue studies | PEGylation of drugs | Biomaterials and skin models |
| FDA status | Not approved as a therapeutic | Used in some cleared devices | Approved in many drug products | Not approved as a drug |
Where Elastin-Like Polypeptides Are Used
- Protein purification: an ELP tag lets a target protein be captured by a simple temperature shift instead of an affinity column.
- Drug delivery: ELP micelles and depots can release a payload when body temperature triggers coacervation.
- Tissue engineering: cross-linked ELP hydrogels serve as scaffolds in cartilage, vascular, and skin research.
- Diagnostics and coatings: the polymer is used to functionalize surfaces and build biosensors.
Most of this work remains preclinical. Elastin-like polypeptides are research tools and investigational materials, not approved therapies for any condition.
Elastin-Like Polypeptides Are Not Skin Care Peptides
Search interest in ELPs overlaps with cosmetic "polypeptide" marketing, and the two ideas are often confused. Products such as drunk elephant protini polypeptide cream and most polypeptide eye cream formulas rely on short signal peptides, hydrolyzed proteins, or copper peptides, which are small topical ingredients rather than elastin-like polypeptides.
Topical peptides act on the skin surface. ELPs are much larger recombinant polymers studied mainly in injectable and laboratory settings, so a cream that lists "polypeptides" on the label is not an ELP product.
Safety, Regulation, and Practical Takeaways
Elastin-like polypeptides are not FDA-approved as drugs, biologics, or cosmetic actives in the United States. Published safety data come from preclinical studies, where ELPs have generally shown low toxicity and low immunogenicity in animal models.
Key points to keep in mind:
- ELPs are recombinant, sequence-defined polymers, not tissue extracts.
- Their phase behavior is tunable through sequence, length, concentration, and salt.
- No elastin-like polypeptide therapeutic is currently approved for human use in the US.
Anyone considering an experimental ELP-based product should talk with a licensed healthcare professional before using it.
Frequently Asked Questions
What is an elastin-like polypeptide made of?
Elastin-like polypeptides are made of repeating pentapeptides with the pattern VPGXG, where X is a guest residue that can be almost any amino acid except proline. They are produced by engineered cells reading a synthetic DNA sequence, so the final polymer is a recombinant protein rather than a tissue extract.
Are elastin-like polypeptides approved for human use?
No. Elastin-like polypeptides are not FDA-approved as drugs, biologics, or cosmetic actives, and no ELP product is currently cleared to treat a medical condition in the United States. Safety and effectiveness data come from preclinical laboratory and animal studies. Anyone considering an experimental ELP-based product should consult a licensed healthcare professional first.
How is an elastin-like polypeptide different from the peptides in skin care?
Cosmetic peptides are typically short chains of a few amino acids, such as signal peptides or copper peptides, applied topically to the skin surface. Elastin-like polypeptides are much larger recombinant polymers with an engineered repeating sequence, and they are studied mainly for injectable and laboratory applications. A skin cream that lists "polypeptides" on the label is not an ELP product.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.